Position in SANA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,759,872
+$120,620 QoQ
Shares Held
504,262
-11.4% QoQ
Ownership
0.168%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#35
of 211 holders
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 0%
Shared 99%
None 1%
Common Shares in SANA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $14,221,834,024 across 296 Biotechnology names. SANA ranks #122 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,043,052 | $3,995,225,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,940,665 | $2,457,162,245 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,754,318 | $1,130,162,341 | |
| 4 | INCY |
Incyte Corp
|
4,080,461 | $462,561,050 | |
| 5 | ARGX |
Argenx SE
|
443,990 | $411,920,598 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
1,671,684 | $409,178,086 | |
| 7 | MRNA |
Moderna, Inc.
|
5,780,299 | $404,794,337 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
1,201,644 | $379,827,645 |
All Filings in SANA
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,759,872 | 504,262 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,639,252 | 569,186 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $2,286,667 | 561,835 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $1,607,286 | 452,757 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $745,236 | 272,981 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $278,283 | 165,646 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $79,057 | 48,502 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $196,267 | 47,180 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $252,709 | 46,284 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $410,840 | 41,084 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $462,647 | 113,394 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $406,020 | 104,915 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $617,050 | 103,532 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $349,568 | 106,902 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $150,995 | 38,227 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $230,724 | 38,454 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,823,772 | 750,198 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $307,213 | 37,193 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $555,931 | 35,913 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $669,497 | 29,729 | Shares | Defined | 2021-11-15 | |
| 2021-03-31 | $824,466 | 24,633 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||